Ashot Avagimyan is an expert in Cardiology at Yerevan State Medical University (Armenia). As of October 2026, ScienceLeadR ranks Ashot Avagimyan in the top 1% of experts in Armenia for Glucose Metabolism Disorders. Ashot Avagimyan has authored 65 publications, the most recent in 2026. SLR score: 260 (community average: 125). How the SLR is computed.

LeadR Profile

Ashot Avagimyan Yerevan State Medical University Armenia
260 ScienceLeadR Reputation 260
Network Map

Cardiology

Subspecialties: Pharmacy - Endocrinology - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2019 - 2026

Source: PubMed

Yerevan State Medical University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 65

Citations

Citations: 348 1st author: 38 Last author: 4 Unique author: 2


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Lifestyle strategies and nutraceuticals in chronic venous disease: an evidence-weighted synthesis and clinical positioning.
PMID 42828782 — quality of life, life style, phenotype, ulcer, adiposity, diet, parenteral nutrition, flavonoids, enteral nutrition, weight control
Clin Nutr20260
Targeting the Gut-Bone Axis with Prebiotics, Probiotics, Synbiotics, and Postbiotics: From Mechanistic Plausibility to Clinical Bone Outcomes.
PMID 42796950 — bone remodeling, synbiotics, food, prebiotics, osteoporosis, probiotics, gastrointestinal microbiome
Nutrients20260
Mesenteric Panniculitis and the Gut-Mesentery-Metabolic Axis: A Hypothesis-Generating Narrative Review.
PMID 42792759 — dysbiosis, precision medicine, tissues, gastrointestinal microbiome, panniculitis
Biomedicines20260
Tumoral Metabolism at the Intersection of Oncogene Signaling, Epigenetics and Immunology: Emerging Therapeutic Strategies in Cancer.
PMID 42510963 — oncogenes, cells, stress, physiological, neoplasms, mitochondrial dynamics, therapeutics, tumor microenvironment, immunology
Curr Issues Mol Biol20260
Natural supplements in breast cancer therapy: translational evidence, clinical safety, and emerging challenges.
PMID 42147231 — luteolin, safety, breast neoplasms, quercetin, neoplasms, breast, curcumin, therapeutics, resveratrol
Front Oncol20260

LeadR Networks

Main global connection map